Cargando…
Inhibitory effect of baicalein combined with gemcitabine in human pancreatic cancer cell lines
Pancreatic cancer is an aggressive disease with a particularly poor prognosis contributing to a substantial percentage of cancer-associated mortality rates. In the present study, the combination treatment of baicalein (BAI) and gemcitabine (GEM) was investigated to examine whether it inhibited the g...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840621/ https://www.ncbi.nlm.nih.gov/pubmed/29552186 http://dx.doi.org/10.3892/ol.2018.8043 |